Cemdisiran, a potential new drug for the treatment of generalized myasthenia gravis, has been accepted for priority review by ...

This recommendation represents an important step towards improving access for Canadians living with rare kidney diseases ...

A man in his late 70s, Albert has always led a full life. From his home in rural Texas, he runs his family farm, oversees ...

A senior executive of the world gold trading association has hailed Hong Kong's launch of a central clearing system as a ...

Germany is expanding its emerging territorial missile defense system, with the the country’s armed ...

China’s membership is not a threat. Rather, it is a sustainable framework for the United States to prosper. Both sides could ...

Scaling AI inside large organizations demands genuine buy-in across teams, thoughtful change management, and clear oversight ...

Thermo Fisher Scientific, the world leader in serving science, today announced that the Applied Biosystems™ RapidINTEL™ Plus Cartridge has received approval from the Federal Bureau of Investigation ...

ABB has entered into an agreement to acquire Tønsberg, Norway-headquartered marine automation specialist Høglund AS, ...

InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV)The Company is assessing the most efficient de ...

As part of new procurements announced at the summit in Ankara, NATO will buy up to five MQ-4C Triton to complement the RQ-4Ds ...

DIMAPUR: Artificial Intelligence (AI) has the potential to make healthcare more accessible, affordable and efficient, but it should complement doctors rather than replace them, said Dr. D. Nageshwar ...